Stivarga has just been approved in Japan for the treatment of GIST. Keep reading for more information.Official Stivarga Press Release:Bayer HealthCare has received approval from the Japanese authorities (MHLW) for the marketing of Regorafenib (Stivarga) [...]
The GIST Cancer Journal is the first journal specifically focused on Gastrointestinal Stromal Tumors (GIST). Keep reading for more information.The GIST Cancer Journal Official Press Release:CONTACT/MEDIA INQUIRIES: Erin Kristoff, Marketing and Communications DirectorThe Life Raft GroupWayne Plaza [...]
Alianza GIST has set forth a plan to strengthen the coalition in Latin America. Keep reading for the official press release and more information about Alianza GIST.
Yesterday, there were a series of news stories reporting on an article published by Cooke et al inCancer Cell. Unfortunately, the coverage gave misleading information which could suggest that patients should not take Gleevec (imatinib) or Sutent (sunitinib).